Open-Labeled European Study To Support The Early Identification Of Patients With Chronic Neuropathic Low Back Pain In Primary Care And To Assess The Effectiveness And Tolerability Of Pregabalin In This Population.

Trial Profile

Open-Labeled European Study To Support The Early Identification Of Patients With Chronic Neuropathic Low Back Pain In Primary Care And To Assess The Effectiveness And Tolerability Of Pregabalin In This Population.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 12 Oct 2012

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Back pain; Neuropathic pain
  • Focus Therapeutic Use
  • Acronyms PINPOINT
  • Sponsors Pfizer
  • Most Recent Events

    • 18 Apr 2012 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 14 Apr 2012 Additional trial locations (Finland and Greece) added as reported by European Clinical Trials Database.
    • 06 Apr 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top